{
  "paper_metadata": {
    "pmid": "29019809",
    "title": "Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients",
    "extraction_summary": "Extracted information on the TTR gene variant Val30Met, including penetrance data and individual patient records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 63,
        "demographics": "Median age at onset 45 years (range, 25-66 years); Median age at LTx 50 years (range, 27-69 years)",
        "phenotype": "Hereditary transthyretin amyloidosis (ATTRm) with CNS complications and atrial fibrillation"
      },
      "penetrance_data": {
        "total_carriers_observed": 63,
        "affected_count": 25,
        "unaffected_count": 38,
        "uncertain_count": null,
        "penetrance_percentage": 39.68,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": 45,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "Developed CNS complications",
          "evidence_sentence": "Twenty-five patients had developed 1 or more CNS complications at a median of 21 years after onset of disease."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": 50,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "unaffected",
          "phenotype_details": "No CNS complications reported",
          "evidence_sentence": "The remaining 38 patients did not develop CNS complications."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation in TTR is associated with hereditary transthyretin amyloidosis, leading to amyloid deposition and various complications.",
        "assays": []
      },
      "segregation_data": "The Val30Met variant is known to segregate with disease in families affected by hereditary transthyretin amyloidosis.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study focused on patients with the Val30Met mutation specifically.",
      "key_quotes": [
        "The estimated median survival from onset of disease was 27 years for the 63 included patients.",
        "Twenty-five (40%) patients had developed 1 or more CNS event."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data was primarily focused on the Val30Met variant in the TTR gene."
  }
}